Autoimmune Progesterone Dermatitis: A Systematic Review

Overview of attention for article published in Dermatitis, August 2021

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 2 news outlets
twitter: 3 X users

reddit: 1 Redditor
podcasts: 1 podcast

Readers on

mendeley: 20 Mendeley

So far, Altmetric has seen 2 news stories from 2 outlets.

REGENERON PHARMACEUTICALS : New dupixent (dupilumab) data in patients as young as six years old with moderate-to-severe atopic dermatitis to be presented at wcpd and eadv

MarketScreener, 22 Sep 2021

More than 30 presentations reinforce the role of Dupixent in targeting IL-4 and IL-13, key drivers of the type 2 inflammation…

New Dupixent® (dupilumab) Data In Patients As Young As 6 Years Old With Moderate-to-severe Atopic Dermatitis To Be Presented At WCPD And EADV

The Street, 21 Sep 2021

New Dupixent ® (dupilumab) data in patients as young as 6 years old with moderate -to-severe a topic dermatitis to be presented…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity.